767355-26-0

Basic information

• Product Name: (E)-3-(2,5-difluorophenyl)prop-2-en-1-ol
• Synonyms: (E)-3-(2,5-difluorophenyl)prop-2-en-1-ol
• CAS NO: 767355-26-0
• Molecular Formula: C₉H₈F₂O
• Molecular Weight: 170.1560264
• Mol File: 767355-26-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (E)-3-(2,5-difluorophenyl)prop-2-en-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-3-(2,5-difluorophenyl)prop-2-en-1-ol(767355-26-0)
• EPA Substance Registry System: (E)-3-(2,5-difluorophenyl)prop-2-en-1-ol(767355-26-0)

Safety Data

• Hazardous Substances Data: 767355-26-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(E)-3-(2,5-difluorophenyl)prop-2-en-1-ol is used as a building block for the synthesis of various drugs, contributing to the development of new pharmaceutical products. Its unique chemical structure allows for the creation of a wide range of therapeutic agents.
Used in Agricultural Industry:
In the agricultural sector, (E)-3-(2,5-difluorophenyl)prop-2-en-1-ol is utilized as a key component in the synthesis of agrochemicals, such as pesticides and herbicides, which are essential for maintaining crop health and productivity.
Used in Flavor and Fragrance Industry:
(E)-3-(2,5-difluorophenyl)prop-2-en-1-ol is used as an intermediate in the production of flavors and fragrances, adding to the diversity and complexity of scents and tastes in the consumer market.
Used in Research and Development:
(E)-3-(2,5-difluorophenyl)prop-2-en-1-ol is used as a subject of study for its potential anti-inflammatory and antioxidant properties, with the aim of discovering novel applications in the fields of medicine and healthcare.

Upstream product

• 375368-91-5 ethyl (E)-3-(2,5-difluorophenyl)acrylate 
• 112898-33-6 3-(2,5-difluorophenyl)acrylic acid 
• 1007862-01-2 methyl (2E)-3-(2,5-difluorophenyl)-2-propenoate 

Downstream Products

• 1197396-81-8 (1R)-1-[(4-{[(2E)-3-(2,5-difluorophenyl)-2-propen-1-yl]amino}-1-piperidinyl)methyl]-1,2-dihydro-4H,9H-imidazo[1,2,3-ij]-1,8-naphthyridine-4,9-dione 
• 917343-02-3 tert-butyl {1-[(2E)-3-(2,5-difluorophenyl)prop-2-en-1-yl]piperidin-4-yl}carbamate 
• 1350756-11-4 (E)-3-(2,5-difluorophenyl)allyl acetate 
• 149946-42-9 2-[(1E)-3-chloroprop-1-en-1-yl]-1,4-difluorobenzene 
• 872263-26-8 (E)-3-(2,5-difluorophenyl)acrylaldehyde 
• 1093219-10-3 [(1RS)-1-{(2S,5R)-5-[(E)-3-(2,5-difluoro-phenyl)-allylamino]-tetrahydropyran-2-yl}-2-(6-methoxy[1,5]naphthyridin-4-yl)-ethyl]-carbamic acid benzyl ester 
• 1093218-54-2 {(3R,6S)-6-[(1S)-1-amino-2-(6-methoxy[1,5]naphthyridin-4-yl)-ethyl]-tetrahydropyran-3-yl}-[3-(2,5-difluorophenyl)-allyl]-amine 
• 1093218-81-5 {(3R,6S)-6-[(1R)-1-amino-2-(6-methoxy[1,5]naphthyridin-4-yl)-ethyl]-tetrahydropyran-3-yl}-[(E)-3-(2,5-difluorophenyl)-allyl]-amine 
• 1073495-60-9 (1R)-1-[(4-{[(2E)-3-(2,5-difluorophenyl)-2-propen-1-yl]amino}-1-piperidinyl)methyl]-9-fluoro-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one 

Relevant articles and documents

Solid-phase synthesis and biological evaluation of piperazine-based novel bacterial topoisomerase inhibitors

There is an emerging global need for new and more effective antibiotics against multi-resistant bacteria. This situation has led to massive industrial investigations on novel bacterial topoisomerase inhibitors (NBTIs) that target the vital bacterial enzym

4-(1-AMINO-ETHYL)-CYCLOHEXYLAMINE DERIVATIVES

The invention relates to compounds of formula (I) wherein R0 represents H or OH; R1 represents alkoxy; U and W represent N, V represents CH and R2 represents H or F, or U and V represent CH, W represents N and R2 /su

TRICYCLIC NITROGEN CONTAINING COMPOUNDS AND THEIR USE AS ANTIBACTERIALS

Compounds of Formula (I) or a pharmaceutically acceptable salt or N-oxide thereof; Formula (I) (relative stereochemistry shown) wherein: Z1, Z2 , L are as defined, U represents a cyclic group selected from: phenyl, pyridyl, pyridazin

TRICYCLIC COMPOUNDS AS ANTIBACTERIALS

Tricyclic nitrogen containing compounds of formula (I) and their use as antibacterials.

4-(1-AMINO-ETHYL)-CYCLOHEXYLAMINE DERIVATIVES

The invention relates to compounds of formula (I) wherein R0 represents H or OH; R1 represents alkoxy; U and W represent N, V represents CH and R2 represents H or F, or U and V represent CH, W represents N and R2/sup

3-AMINO-6-(1-AMINO-ETHYL)-TETRAHYDROPYRAN DERIVATIVES

The invention relates to antibacterial compounds of formula I wherein R1 represents halogen or alkoxy; U and W each represent N, V represents CH and R2 represents H or F, or U and V each represent CH, W represents N and R2

ETHANOL OR 1,2-ETHANEDIOL CYCLOHEXYL ANTIBIOTIC DERIVATIVES

The invention relates to antibiotic ethanol or 1,2-ethanediol cyclohexyl derivatives of formula (I) wherein R1 represents (C1-C4)alkoxy; one or two of U, V, W and X represent(s) N and the remaining represent each independently CH or, in the case of V or X

New Piperidine Antibiotics

The invention relates to novel, antibacterially active piperidine derivatives of the formula wherein one of U and V represents N, the other represents N or CH; M represents CH2CH2, CH═CH, CH(OH)CH(OH), CH(OH)CH2, CH(NHsub

TETRAHYDROPYRANE ANTIBIOTICS

The invention relates to antibiotic tetrahydro rane derivatives of formula (I).

ANTIBIOTIC COMPOUNDS

The invention relates to selected antibiotics of formula (Al) wherein R1 represents alkyl, alkoxy, haloalkoxy, halogen or cyano; one or two of U, V, W and X represent(s) N, the remaining represent CH, or, in case of U, V and/or W, may also repr